Capricorn Fund Managers LTD Takeda Pharmaceutical CO LTD Transaction History

Capricorn Fund Managers LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$15.03 - $16.32 $9.97 Million - $10.8 Million	-663,525 Reduced 76.41%	204,892 $3.17 Million
Q2 2023 Jul 12, 2023	BUY	$15.57 - $17.11 $13.5 Million - $14.9 Million	868,417 New	868,417 $13.6 Million
Q3 2022 Nov 09, 2022	BUY	$12.8 - $28.65 $3.56 Million - $7.96 Million	277,783 New	277,783 $3.6 Million
Q1 2022 May 10, 2022	SELL	$13.54 - $15.35 $21.2 Million - $24.1 Million	-1,568,306 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $20.7 Million - $25.7 Million	1,568,306 New	1,568,306 $21.4 Million

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Capricorn Fund Managers LTD, based on Form 13F filings with the SEC.

Stay updated on Capricorn Fund Managers LTD with notifications on news.